Molecular Therapy - Nucleic Acids

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 3, Pages (March 2008)
CRISPR + CAS = Defensive or Immune System
Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells
In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging success. In vivo.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Genomics for Regional Development
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Volume 9, Issue 3, Pages (November 2014)
Transduction of Human Embryonic Stem Cells by Foamy Virus Vectors
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 154, Issue 6, Pages (September 2013)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Volume 13, Issue 6, Pages (December 2013)
Haiyan Dong, Ji Ma, Jie Wang, Zai-Sheng Wu, Patrick J Sinko, Lee Jia 
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Molecular Therapy - Nucleic Acids
Volume 7, Issue 3, Pages (September 2016)
Jan Hoinka, Phuong Dao, Teresa M Przytycka 
Molecular Therapy - Methods & Clinical Development
Volume 154, Issue 6, Pages (September 2013)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
High-accuracy biodistribution analysis of adeno-associated virus variants by double barcode sequencing  Damien Marsic, Héctor R Méndez-Gómez, Sergei Zolotukhin 
Volume 10, Issue 6, Pages (June 2018)
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
Volume 9, Issue 4, Pages (October 2017)
Volume 16, Issue 5, Pages (May 2008)
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
Wei-Yun Lai, Bo-Tsang Huang, Jen-Wei Wang, Pei-Ying Lin, Pan-Chyr Yang 
Olivier Humbert, Nancy Maizels  Molecular Therapy - Nucleic Acids 
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 19, Issue 4, Pages (April 2011)
Volume 25, Issue 2, Pages (February 2017)
APOE Gene Targeting (A) Schematic representation of the endogenous APOE locus, the gene targeting vector and the targeted APOE locus. The exons of the.
Molecular Therapy - Nucleic Acids
iRNA-PseU: Identifying RNA pseudouridine sites
Molecular Therapy - Nucleic Acids
Volume 23, Issue 3, Pages (March 2015)
Volume 19, Issue 5, Pages (May 2011)
Efficient Sleeping Beauty DNA Transposition From DNA Minicircles
Volume 17, Issue 2, Pages (August 2015)
Effect of Genome Size on AAV Vector Packaging
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
Molecular Therapy - Nucleic Acids
Volume 16, Issue 2, Pages (February 2015)
Molecular Therapy - Nucleic Acids
Jia Liu, Thomas Gaj, Mark C Wallen, Carlos F Barbas 
Generate TALE/TALEN as Easily and Rapidly as Generating CRISPR
Molecular Therapy - Nucleic Acids
Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia  Marie Reine Haddad, Anthony.
Molecular Therapy - Methods & Clinical Development
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Volume 9, Issue 4, Pages (April 2016)
Biao Dong, Hiroyuki Nakai, Weidong Xiao  Molecular Therapy 
Fang Wang, Yunfeng Wang, Jie Ding, Jiyun Yang  Kidney International 
Volume 27, Issue 13, Pages e4 (June 2019)
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Molecular Therapy - Nucleic Acids CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells  Xianglian Ge, Haitao Xi, Fayu Yang, Xiao Zhi, Yanghua Fu, Ding Chen, Ren-He Xu, Ge Lin, Jia Qu, Junzhao Zhao, Feng Gu  Molecular Therapy - Nucleic Acids  Volume 5, (January 2016) DOI: 10.1038/mtna.2016.100 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Schematic representation of CRISPR/Cas9-AAV at human NRL locus. (a) Schematic of the human NRL locus. sgRNAs and PAMs are labeled with gray line and red line, respectively. (b) Schematic representation of the vector for gene targeting. Blank boxes represent the coding sequence of NRL gene. Blue boxes represent the left and right homologous arms. Red box represents DsRed gene, the white box represents the coding region of the neo gene (NEO) and PGK promoter. (c) Targeted allele with homologous recombination. One of primers F1/R1 and F2/R2 locates outside of the homologous arms, respectively. PCR products will be obtained (824 and 823 base pairs with F1/R1 and F2/R2, respectively) with templates of genomic DNA from cells with homologous recombination. AAV, adeno-associated virus; CRISPR, Clustered interspaced short palindromic repeats; Cas9, CRISPR associated protein 9; PCR, polymerase chain reaction. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.100) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Generation of H9 NRL knock-in. (a) Schematic of protocol for NRL-KI in H9. (b) Bright-field phase images of the H9 cells (Parental cells, P) and NRL knock-in cells. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.100) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Polymerase chain reaction (PCR) analysis and confirmation of NRL knock-in. (a) PCR analysis identified colony 2 has DsRed gene knock-in at NRL locus. Location of F1/R1 and F2/R2 are illustrated in Figure 1c. (b) 5′ terminal PCR (with primers F1R1) products were digested with restriction enzyme EcoRI. P, parental cells. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.100) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Characterization of NRL knock-in colony. (a) Reverse transcription-polymerase chain reaction (RT-PCR) analysis showed the expression of SOX 2, OCT4, and NANOG in knock-in colony with different passages (5 and 10). (b) OCT4 immunostaining analysis of H9 and NRL knock-in colony at passage 10. P, parental cells. Molecular Therapy - Nucleic Acids 2016 5, DOI: (10.1038/mtna.2016.100) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions